£520.00

This is the most expensive it has ever been. Walk away.

£520 today · previous high £520 · all-time low £305

CRC Press Antiangiogenic Cancer Therapy

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 28 days · 28 data points (no recent data)

Historical
Generating forecast…
£520.00 £283.50 £335.10 £386.70 £438.30 £489.90 £541.50 25 July 2026 31 July 2026 07 August 2026 14 August 2026 21 August 2026
View at Amazon ↗

Price data last checked 63 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 28 days • 2 price levels

Days at Price
Current Price
12 days 16 days · current 0 4 8 12 16 £305 £520 Days at Price

Price Analysis

Most common price: £520 (16 days, 57.1%)

Price range: £305 - £520

Price levels: 2 different prices over 28 days

Description
Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors. Compiles the results of four decades of progress Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject. Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment. Covers specific molecular targets for inhibiting angiogenesis in cancer therapy. Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors. Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers. This volume celebrates progress made in four decades, and more importantly, it provi About the Author Darren W. Davis, Roy S. Herbst, James L. Abbruzzese

Key Features

Used Book in Good Condition

Product Specifications
Brand
CRC Press
Format
hardcover
ASIN
0849327997
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain
Amazon UK
Release Date
25 July 2007
Listed Since
01 February 2007

Barcode

No barcode data available

Similar Products You Might Like

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)
97% match

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)

Springer

£133.24 05 Sep 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
96% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.67 24 Sep 2026
Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
96% match

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Elsevier

£131.39 20 Aug 2026
Animal Models in Cancer Drug Discovery
96% match

Animal Models in Cancer Drug Discovery

Elsevier

£115.37 30 Sep 2026
Wiley A Beginner's Guide to Targeted Cancer Treatments
96% match

Wiley A Beginner's Guide to Targeted Cancer Treatments

Wiley

£44.89 26 Sep 2026
The Tumor Microenvironment (Cancer Drug Discovery and Development)
96% match

The Tumor Microenvironment (Cancer Drug Discovery and Development)

Humana

£140.12 21 Aug 2026
Abeloff's Clinical Oncology
96% match

Abeloff's Clinical Oncology

Elsevier

£227.94 21 Aug 2026
A Beginner's Guide to Targeted Cancer Treatments
96% match

A Beginner's Guide to Targeted Cancer Treatments

Wiley

£41.95 04 Sep 2026
Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy
96% match

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Springer

£247.81 05 Sep 2026
Cancer Chemotherapy: Basic Science to the Clinic
96% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley

£50.26 08 Sep 2026
Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology
96% match

Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology

Springer

£104.40 29 Sep 2026
Signaling Pathways and Molecular Mediators in Metastasis - Springer
96% match

Signaling Pathways and Molecular Mediators in Metastasis - Springer

Springer

£90.47 03 Oct 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Elsevier

£120.98 22 Sep 2026
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
96% match

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Elsevier

£20.00 30 Sep 2026
Cancer Biology
96% match

Cancer Biology

Oxford University Press

Price unavailable
Onco-Nephrology
96% match

Onco-Nephrology

Elsevier

£119.87 03 Sep 2026
McGraw-Hill The Basic Science of Oncology, 6th Edition
96% match

McGraw-Hill The Basic Science of Oncology, 6th Edition

McGraw-Hill Education

£115.56 26 Sep 2026
Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)
96% match

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Springer

£60.42 02 Oct 2026
Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study
96% match

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study

Elsevier

£111.99 24 Sep 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
96% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.81 18 Sep 2026
Vascular Surgery in Oncology
96% match

Vascular Surgery in Oncology

Springer

£156.70 30 Sep 2026
Guidance Molecules in Cancer and Tumor Angiogenesis (Advances in Cancer Research): Volume 114
96% match

Guidance Molecules in Cancer and Tumor Angiogenesis (Advances in Cancer Research): Volume 114

Elsevier

£104.00 24 Sep 2026
Evidence–Based Oncology (Evidence–Based Medicine)
96% match

Evidence–Based Oncology (Evidence–Based Medicine)

Wiley-Blackwell

£99.87 21 Aug 2026
The Story of Hydra: Portrait of Cancer as a Stem-Cell Disease
96% match

The Story of Hydra: Portrait of Cancer as a Stem-Cell Disease

£203.99 25 Sep 2026